PP-41 Risk assessment for compatibility of rhigf-1/rhigfbp-3 with commonly administered neonatal intravenous medications based on an experimental model
PP-41 Risk assessment for compatibility of rhigf-1/rhigfbp-3 with commonly administered neonatal intravenous medications based on an experimental model